Clinical Trial Update: MS Relapses During COVID-19 Pandemic

View source ↗

Summary

A completed clinical trial studying relapses in multiple sclerosis during the COVID-19 pandemic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Relapsing-remitting Multiple Sclerosis

Snippet

Sponsor: Nottingham University Hospitals NHS Trust | Conditions: Multiple Sclerosis, Covid19 | Status: COMPLETED